RITUXIMAB BETA
UNII WW3AY3N8RS

Substance Identification & Data

This profile provides standardized clinical and technical data for Rituximab Beta, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WW3AY3N8RS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3062244-96-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WW3AY3N8RS

CAS Registry Number

3062244-96-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RITUXIMAB BETA

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13874

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rituximab Beta. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RITUXIMAB BETA

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN CHIMERIC (1-451) (VH (MUS MUSCULUS IGHV1-47-27*01 (99.0%) -(IGHD) -IGHJ1*01 (87.5%) S128>A (121), CDR-IMGT (8.8.14) (26-33.51-58.97-110)) (1-121) -HOMO SAPIENS IGHG1*01, G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (218), V121>A (219) (122-219), HINGE 1-15 (220-234), CH2 (235-344), CH3 D12 (360), L14 (362) (345-449), CHS (450-451)) (122-451)), (224-213')-DISULFIDE WITH L-KAPPA LIGHT CHAIN CHIMERIC (1'-213') (V-KAPPA (MUS MUSCULUS IGKV4-72*01 (95.8%) -IGKJ1*01 (100%), CDR-IMGT (5.3.9) (27'-31'.49'-51'.88'-96')) (1'-106') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (152'), V101 (190')) (107'-213')); DIMER (230-230:233-233)-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL GB241 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GB241 .KAPPA.-CHAIN, DIMER (RITUXIMAB BETA)

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS MS4A1 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1, CD20)), CHIMERIC MONOCLONAL ANTIBODY (RITUXIMAB BETA)

RITUXIMAB AFUCOSYLATED GLYCOFORM

RITUXIMAB BETA [INN]

External Clinical & Regulatory Resources

Previous UNIIWW35KDG5EW

Next UNIIWW3D681N3D